Medhelp Care Aktiebolag Future Growth
Future criteria checks 5/6
Medhelp Care Aktiebolag is forecast to grow earnings and revenue by 87.4% and 16% per annum respectively. EPS is expected to grow by 88.1% per annum. Return on equity is forecast to be 38.7% in 3 years.
Key information
87.4%
Earnings growth rate
88.1%
EPS growth rate
Healthcare Services earnings growth | 21.6% |
Revenue growth rate | 16.0% |
Future return on equity | 38.7% |
Analyst coverage | Low |
Last updated | 06 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 138 | 18 | 17 | 30 | 1 |
12/31/2025 | 120 | 14 | 13 | 25 | 1 |
12/31/2024 | 99 | 4 | N/A | 11 | 1 |
3/31/2024 | 90 | -11 | -3 | 7 | N/A |
12/31/2023 | 90 | -11 | -1 | 9 | N/A |
9/30/2023 | 90 | -3 | -4 | 7 | N/A |
6/30/2023 | 90 | -2 | -5 | 7 | N/A |
3/31/2023 | 89 | -4 | -25 | -14 | N/A |
12/31/2022 | 87 | -8 | -30 | -17 | N/A |
9/30/2022 | 84 | -14 | -33 | -23 | N/A |
6/30/2022 | 84 | -15 | -32 | -20 | N/A |
3/31/2022 | 84 | -11 | -13 | 1 | N/A |
12/31/2021 | 81 | -8 | -7 | 7 | N/A |
9/30/2021 | 79 | -3 | -4 | 8 | N/A |
6/30/2021 | 77 | -6 | -4 | 4 | N/A |
3/31/2021 | 75 | -5 | 0 | 9 | N/A |
12/31/2020 | 76 | -1 | 0 | 11 | N/A |
12/31/2019 | 62 | 5 | N/A | N/A | N/A |
12/31/2018 | 59 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDHLP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: MEDHLP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MEDHLP is expected to become profitable in the next 3 years.
Revenue vs Market: MEDHLP's revenue (16% per year) is forecast to grow faster than the Swedish market (1.8% per year).
High Growth Revenue: MEDHLP's revenue (16% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDHLP's Return on Equity is forecast to be high in 3 years time (38.7%)